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Abstract 
Background: Pleural effusion is a common 
presenting feature of patients presenting in the 
pulmonology OPD. Examination of pleural fluid 
obtained by thoracocentesis is a simple way to 
diagnose pathologies of the pleura and peripheral 
parts of the lung.  
Objective: To determine the diagnostic yield of 
pleural fluid cytology in malignant pleural effusions 
keeping pleural biopsy as the gold standard. 
Materials and Method: This retrospective study 
was carried out at Pakistan Institute of Medical 
Sciences, Islamabad, from November 2010 to 
November 2011. Twenty six patients (65% females; 
35% males) presenting with pleural effusion in 
whom pleural fluid cytology with concurrent pleural 
biopsy was carried out were included in the study. 
The diagnostic yield of pleural fluid was determined 
keeping pleural biopsy as the gold standard. 
Results: The age range of the patients was 23-76 
years. Pleural fluid was positive for malignant cells 
in 15 out of 26 patients, whereas pleural biopsy 
yielded definite evidence of malignancy in 21 cases. 
In 5 cases diagnosis of atypical infiltrate was 
rendered and immunohistochemistry was suggested 
for confirmation of malignancy. The diagnostic yield 
of pleural fluid cytology came out to be 58%. 
Conclusion:  Pleural fluid cytological examination 
followed by pleural biopsy remains the initial 
diagnostic procedure in management of patients with 
suspected malignant pleural effusion. 
Keyword: Pleural fluid cytology, pleural effusion, 
thoracocentesis, malignant pleural effusion. 
Introduction 
Pleural effusion is a common feature in patients presenting 
in any pulmonology department. Based on laboratory 
findings, it is of two types i.e. transudative and exudative.  
Transudative type of effusion is caused by congestive heart 
failure, nephrotic syndrome, cirrhosis and lymphatic 
obstruction by a tumor. Most common causes of exudative 
pleural effusion in our country are pulmonary tuberculosis 
followed by malignancy.1,2 Malignancy is not only a 
consideration in the elderly but also in the younger patients. 
It is exudative in nature, and poses a diagnostic challenge to 
the treating physicians. 
Malignant pleural effusions are most commonly caused by 
carcinomas of breast, lung, gastrointestinal tract, ovary and 
hematological malignancies. In males the most common 
cause of malignant pleural effusion is lung cancer followed 
by lymphoma and leukemia. In females the leading cause is 
carcinoma of breast followed by female genital tract 
malignancies and primary lung carcinomas.3 
The most commonly carried out procedure in the initial 
investigation of patients with pleural effusion is 
thoracocentesis which may be followed by blind 
percutaneous pleural biopsy or thoracoscopic pleural biopsy 
if the effusion is exudative in nature. Thoracoscopy is the 
procedure of choice in patients with suspected malignant 
pleural effusion, in whom cytology is negative. In this study 
we evaluated the diagnostic yield of pleural fluid cytology in 
malignant pleural effusion in our set up. 
Materials and Methods 
This was a retrospective, observational study carried out at 
Pakistan Institute of Medical Sciences, Islamabad. 
Nonprobability, consecutive type of sampling was done in 
which cases were taken out from the surgical pathology files 
of patients in whom pleural fluid cytology and pleural 
biopsy had been carried out between October 2010 and 
October 2011. Patient’s clinical history or radiological 
findings were not taken into account as they were not 
available in all cases. 
Inclusion criteria: 
1. A pleural biopsy showing definitive evidence of 
malignancy. 
2. Patients in whom pleural fluid cytology and 
subsequently pleural biopsy was carried out 
Exclusion criteria: 
1. Non diagnostic pleural fluid cytology. 
2. Non diagnostic pleural biopsy. 
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Pleural fluid preparation 
The pleural fluid submitted for cytological examination was 
centrifuged and subsequently two slides were made. The 
slides were stained with hematoxylin and eosin. On 
microscopic examination, the findings were stratified in four 
diagnostic categories; Category 1: No malignant cells seen. 
Category 2: Atypical cells seen. Category 3: Atypical cells 
suspicious of malignancy and Category 4: Malignant cells 
seen. Cells designated as; ‘Atypical’ were the ones having 
hyperchromatic nuclei, exhibiting variable degree of 
pleomorphism and variable amount of cytoplasm, but the 
features fell short of clear cut evidence of malignancy. 
Malignant cells were defined as cells exhibiting marked 
pleomorphism, having hyperchromatic nuclei and high N/C 
ratio. 
Pleural biopsy preparation 
The pleural biopsy specimens received were fixed in 10% 
formalin, embedded in paraffin wax after completion of 
processing and subsequently stained with hematoxylin and 
eosin. On microscopic examination two diagnostic 
categories were made; Category 1: Cases in which there was 
a definitive evidence of malignancy and Category 2: Cases 
which showed atypical infiltrate suggestive of malignancy. 
The cases in Category 1 showed variable arrangement of 
malignant cells which may be in the form of sheets or 
glandular arrangement with the cells exhibiting marked 
pleomorphism, having hyperchromatic nuclei and high N/C 
ratio. Cases in Category 2 revealed cells exhibiting 
pleomorphism and having hyperchromatic nuclei and high 
N/C ratio but either due to scanty nature of biopsy or 
questionable invasion, with features falling short of clear cut 
evidence of malignancy. The cytology and the biopsy cases 
were examined by a senior resident and a consultant 
histopathologist at two different occasions and allocated a 
category so as to remove any bias. 
All data were analyzed using Statistical Package for Social 
Sciences (SPSS) version 10 for this study. For numerical 
data mean and standard deviation were determined. 
Qualitative data e.g. gender were expressed in terms of 
frequency. At the end diagnostic yield was calculated (total 
number of cases positive in cytology divided by the total 
number of cytology cases). 
Results 
The total number of patients was 26. The age range of the 
patients was 23-76 years, with the mean age being 
55.6±12.7 SD years. The median age was 55.5 years. The 
gender distribution showed a female predominance (Figure 
1). Most of the female patients of malignant pleural effusion 
were middle aged, whereas male patients with malignant 
pleural effusion were elderly (Figure 2). 
The distribution of cytological diagnosis in each category is 
shown in Table 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Most of the cases belonged to the category 1 (negative for 
malignant cells). All cases belonging to category 2, 3 & 4 
were assigned as positive for malignancy. In routine practice 
as well, all cases diagnosed as malignant or atypical are 
investigated further in the work up for malignant cases. 
Based on these criteria the number of positive cases on 
cytology was 15 out of 26 (58%). 
 
 
 
 
 
 
 
 
 
 
Pleural biopsy provided conclusive evidence of malignancy 
in 21 cases and these cases were placed in category 1 
(Malignant). In 3 out of 21 cases, diagnosis of mesothelioma 
was favored and in 8 cases the diagnosis of adenocarcinoma 
was favored. In the rest of 10 cases a diagnosis of malignant 
neoplasm was made and immunohistochemistry was 
suggested for confirmation of diagnosis.  5 cases belonged 
to category 2 (atypical infiltrate suggestive of malignancy) 
and comment was made that immunohistochemistry was 
required for confirmation of diagnosis and exact subtyping 
of tumor. Amongst these 5 cases, two cases were 
cytologically negative for malignancy. Each of the 
remaining three cases was cytologically categorized as 
belonging to category 2, 3 and 4. Of the cases that were 
diagnosed as malignant neoplasm on biopsy there were nine  
cases in which cytology was negative for malignancy, eight 
cases belonged to category 4, two cases placed in category 3 
and one case to category 2. 
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Fig.3: Malignant neoplasm 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.5: Malignant cells – category 3 
 
Table 1. Distribution of cytology cases 
Category of cytological cases Number of cases (%) 
Category 1 11 (42.3) 
Category 2 2 (7.7) 
Category 3 4 (5.4) 
Category 4 9 (34.6) 
Immunohistochemistry was suggested for definitive 
diagnosis in cases in which a diagnosis of adenocarcinoma 
or mesothelioma was favored.  Immunohistochemical 
markers required for this differentiation were not available 
at our center during the period of study, therefore these 
cases were referred to other specialized centers. 
 Discussion 
The annual incidence of malignant pleural effusion in USA 
is 150,000 cases.4The cytological examination of the pleural 
fluid is the investigation of choice in patients with suspicion 
of malignant pleural effusion (MPE) as it is a simple and 
rapid procedure.  Not all the pleural effusions developing in 
a patient of known malignancy are malignant. Some are 
negative on cytology as well as biopsy. These are termed as 
paramalignant effusion. The reasons for development of a 
paramalignant effusion include: bronchial obstruction, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4:Malignant neoplasm suggestive of mesothelioma 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.6: Atypical cells - category 4 
lymphatic duct obstruction, post obstruction pneumonitis, 
lymph node enlargement and pulmonary emboli. Other 
causes of pleural effusion include underlying cardiac 
disease, liver disease and renal disease, these are termed as 
nonmalignant effusions. 
Establishment of the exact cause of MPE is very important 
as the mean survival of the patient following a diagnosis of 
malignant pleural effusion is 3-6 months. Furthermore, it is 
an indicator of surgical incurability and precludes the need 
for further investigations.5 In contrast, paramalignant pleural 
effusion may be amenable to surgical resection and non 
malignant pleural effusion may be treated by treating the 
underlying disease. 
This study highlights the importance of initial pleural fluid 
cytological examination in patients suspected of having a 
malignant pleural effusion. The diagnostic yield in our study 
was 58%. In a study carried out by Ong KC et al on 103 
patients, positive results of initial pleural fluid cytological 
examination was 48.5%.6  Various studies have shown 
different diagnostic yields of pleural fluid cytology ranging 
from 60-90%.7A study done in Pakistan on 150 patients 
revealed a very low diagnostic yield i.e. 8%.8Despite the 
development of new diagnostic procedures cytological 
examination of the pleural fluid followed by closed pleural 
biopsy remain the initial diagnostic procedures, 
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thoracoscopy being reserved for cases not diagnosed by 
closed pleural  biopsy. 9 
Several factors have been shown to influence the diagnostic 
yields in various reports. To begin with the different 
proportions of malignant, para malignant and non malignant 
cases affect the yield of fluid cytology in a manner such that 
if the study has a majority of non malignant cases then the 
diagnostic yield that will come at end will be small. Then, 
location and type of tumor also has a great influence on 
whether the cytology will be negative or positive. A tumor 
located in the central bronchi which are mostly squamous 
cell carcinoma or small cell carcinoma is less likely to 
produce a malignant effusion as compared to peripherally 
situated adenocarcinomas. Other factors which influence the 
diagnostic yield include specimen handling, volume of fluid 
submitted and extent of pleural involvement. Quick sample 
processing that is within half an hour after reception of the 
sample along with preparation of cell blocks significantly 
increases the yield. Different studies have highlighted that at 
least 30 ml of pleural fluid must be submitted and the entire 
sample must be processed in order maximize the yield. In 
our study the quantity of fluid submitted was approximately 
5 ml. Finally it is said that, greater the extent of pleural 
involvement greater the probability that cytology will be 
positive. 
Despite all the above mentioned factors responsible for 
variation in diagnostic yield of pleural fluid cytology it is 
still the procedure of choice in patient with suspicion of 
malignant pleural effusion, as it is simple cost effective 
procedure which can be performed on out-patient basis 
without any major complication and it has a yield which is 
comparable to that of pleural biopsy.10,11 The major 
drawbacks of this study are a small sample size and its 
retrospective nature. However, there was no bias in this 
study as the cytology and the biopsy cases were examined 
by two different pathologists at two different occasions and 
allocation of cases to each category was not influenced by 
any information provided by the physician. 
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